In the new millennium, indications for splenectomy have expanded. Proper patient selection based on an understanding of the biology of each individual's disease is essential for a favorable outcome. We review the most common diseases for which surgeons may be called on to perform splenectomy and while highlighting potential pitfalls and caveats.
Get full access to this article
View all access options for this article.
References
1.
PachterH.L., GrauJ.The current status of splenic preservation.Adv Surg2000; 34: 137–74.
GroomA.C.The Microcirculatory Society Eugene M. Landis award lecture. Microcirculation of the spleen: new concepts, new challenges.Microvasc Res1987; 34: 269–89.
4.
KatzS.C., PillarisettyV.G., BleierJ.I.Liver sinusoidal endothelial cells are insufficient to activate T cells.J Immunol2004; 173: 230–5.
5.
JandlJ.H., AsterR.H.Increased splenic pooling and the pathogenesis of hypersplenism.Am J Med Sci1967; 253: 383–98.
6.
AsterR.H.Pooling of platelets in the spleen: role in the pathogenesis of ‘hypersplenic’ thrombocytopenia.J Clin Invest1966; 45: 645–57.
7.
JandlJ.H., GreenbergM.S., YonemotoR.H., CastleW.B.Clinical determination of the sites of red cell sequestration in hemolytic anemias.J Clin Invest1956; 35: 842–67.
8.
PillarisettyV.G., ShahA.B., MillerG.Liver dendritic cells are less immunogenic than spleen dendritic cells because of differences in subtype composition.J Immunol2004; 172: 1009–17.
9.
KatzS.C., PillarisettyV.G., BleierJ.I.Conventional liver CD4 T cells are functionally distinct and suppressed by environmental factors.Hepatology2005; 42: 293–300.
10.
LuxS.E., JohnK.M.Isolation and partial characterization of a high molecular weight red cell membrane protein complex normally removed by the spleen.Blood1977; 50: 625–41.
11.
BrownE.J., HoseaS.W., FrankM.M.The role of the spleen in experimental pneumococcal bacteremia.J Clin Invest1981; 67: 975–82.
12.
HammarstromL., SmithC.I.Development of anti-polysaccharide antibodies in asplenic children.Clin Exp Immunol1986; 66: 457–62.
13.
McMillanR.Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura.Semin Hematol2000; 37: 239–48.
14.
MusserG., LazarG., HockingW., BusuttilR.W.Splenectomy for hematologic disease. The UCLA experience with 306 patients.Ann Surg1984; 200: 40–5.
15.
KojouriK., VeselyS.K., TerrellD.R., GeorgeJ.N.Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications.Blood2004; 104: 2623–34.
16.
WilhelmM.C., JonesR.E., McGeheeR.Splenectomy in hematologic disorders. The ever-changing indications.Ann Surg1988; 207: 581–9.
17.
BowdlerA.J.The role of the spleen and splenectomy in autoimmune hemolytic disease.Semin Hematol1976; 13: 335–48.
18.
BalintG.P., BalintP.V.Felty's syndrome.Best Pract Res Clin Rheumatol2004; 18: 631–45.
19.
PereiraJ., VellosoE.D., LoterioH.A.Long-term remission of neutropenia in Felty's syndrome after a short GM-CSF treatment.Acta Haematol1994; 92: 154–6.
WatanabeY., MiyauchiK., HoriuchiA.Concomitant laparoscopic splenectomy and cholecystectomy as an effective and minimally invasive treatment of pyruvate kinase deficiency with gallstones.Surg Endosc2002; 16: 1495.
28.
JohnsonR.M., RavindranathY., el-AlfyM., GoyetteG.Jr.Oxidant damage to erythrocyte membrane in glucose-6-phosphate dehydrogenase deficiency: correlation with in vivo reduced glutathione concentration and membrane protein oxidation.Blood1994; 83: 1117–23.
29.
Al-SalemA.H., NaserullahZ., QaisaruddinS.Splenic complications of the sickling syndromes and the role of splenectomy.J Pediatr Hematol Oncol1999; 21: 401–6.
30.
al-SalemA.H., QaisaruddinS., NasserallahZ., al DabbousI., al Jam'aA.Splenectomy in patients with sickle-cell disease.Am J Surg1996; 172: 254–8.
31.
BadalooA.V., SinghalA., ForresterT.E.The effect of splenectomy for hypersplenism on whole body protein turnover, resting metabolic rate and growth in sickle cell disease.Eur J Clin Nutr1996; 50: 672–5.
32.
PinnaA.D., ArgioluF., MarongiuL., PinnaD.C.Indications and results for splenectomy for beta thalassemia in two hundred and twenty-one pediatric patients.Surg Gynecol Obstet1988; 167: 109–13.
33.
CarrJ.A., ShurafaM., VelanovichV.Surgical indications in idiopathic splenomegaly.Arch Surg2002; 137: 64–8.
34.
CroninC.C., BradyM.P., MurphyC.Splenectomy in patients with undiagnosed splenomegaly.Postgrad Med J1994; 70: 288–91.
35.
TaylorM.A., KaplanH.S., NelsenT.S.Staging laparotomy with splenectomy for Hodgkin's disease: the Stanford experience.World J Surg1985; 9: 449–60.
36.
BangerterM., GriesshammerM., BergmannL.Progress in medical imaging of lymphoma and Hodgkin's disease.Curr Opin Oncol1999; 11: 339–42.
37.
SombeckM.D., MendenhallN.P., KaudeJ.V.Correlation of lymphangiography, computed tomography, and laparotomy in the staging of Hodgkin's disease.Int J Radiat Oncol Biol Phys1993; 25: 425–9.
38.
MartinetO., BettschartV., SchollB., SuterM.Value of laparoscopic staging for Hodgkin disease.Surg Laparosc Endosc Percutan Tech2000; 10: 335–7.
39.
LehneG., HannisdalE., LangholmR., NomeO.A 10-year experience with splenectomy in patients with malignant non-Hodgkin's lymphoma at the Norwegian Radium Hospital.Cancer1994; 74: 933–9.
40.
MorelP., DupriezB., GosselinB.Role of early splenectomy in malignant lymphomas with prominent splenic involvement (primary lymphomas of the spleen). A study of 59 cases.Cancer1993; 71: 207–15.
41.
BermanR.S., FeigB.W., HuntK.K.Platelet kinetics and decreased transfusion requirements after splenectomy for hematologic malignancy.Ann Surg2004; 240: 852–7.
42.
KhouriI., SanchezF., DeisserothA.Leukemias. In: DeVitaV., HellmanS., RosenbergS., eds. Cancer: Principles and Practice of Oncology.Philadelphia: Lippincott-Raven;1997: 2285–321.
43.
BouvetM., BabieraG.V., TermuhlenP.M.Splenectomy in the accelerated or blastic phase of chronic myelogenous leukemia: a single-institution, 25-year experience.Surgery1997; 122: 20–5.
44.
Results of a prospective randomized trial of early splenectomy in chronic myeloid leukemia.The Italian Cooperative Study Group on Chronic Myeloid Leukemia.Cancer1984; 54: 333–8.
45.
CusackJ.C.Jr., SeymourJ.F., LernerS.Role of splenectomy in chronic lymphocytic leukemia.J Am Coll Surg1997; 185: 237–43.
46.
AuW.Y., KlasaR.J., GallagherR.Second malignancies in patients with hairy cell leukemia in British Columbia: a 20-year experience.Blood1998; 92: 1160–4.
47.
KrautE.H., GreverM.R., BouroncleB.A.Long-term follow-up of patients with hairy cell leukemia after treatment with 2'-deoxycoformycin.Blood1994; 84: 4061–3.
48.
MorgensternL., RosenbergJ., GellerS.A.Tumors of the spleen.World J Surg1985; 9: 468–76.
49.
BurkeJ.S.Surgical pathology of the spleen: an approach to the differential diagnosis of splenic lymphomas and leukemias. Part I. Diseases of the white pulp.Am J Surg Pathol1981; 5: 551–63.
50.
GoyalA., BabuS.N., KimV.Hemangioendothelioma of liver and spleen: trauma-induced consumptive coagulopathy.J Pediatr Surg2002; 37: E29.
51.
ChanK.W., SawD.Distinctive, multiple lymphangiomas of spleen.J Pathol1980; 131: 75–81.
MorgensternL., McCaffertyL., RosenbergJ., MichelS.L.Hamartomas of the spleen.Arch Surg1984; 119: 1291–3.
54.
EaslerR.E., DowlinW.M.Primary lipoma of the spleen. Report of a case.Arch Pathol1969; 88: 557–9.
55.
HulbertJ.C., GrafR.Involvement of the spleen by renal angiomyolipoma: metastasis or multicentricity?J Urol1983; 130: 328–9.
56.
PopperH., ThomasL.B.Alterations of liver and spleen among workers exposed to vinyl chloride.Ann N Y Acad Sci1975; 246: 172–94.
57.
RapparotH.Tumors of the hematopoietic system. In: Pathology AFIo, ed. Atlas of Tumor Pathology.Washington, DC; 1966.
58.
BowneW.B., LewisJ.J., FilippaD.A.The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature.Cancer1999; 85: 706–17.
59.
MacheersS.K., MansourK.A.Management of isolated splenic metastases from carcinoma of the lung: a case report and review of the literature.Am Surg1992; 58: 683–5.
60.
NiederauC., HaussingerD.Gaucher's disease: a review for the internist and hepatologist.Hepatogastroenterology2000; 47: 984–97.
61.
WeinrebN.J., CharrowJ., AnderssonH.C.Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry.Am J Med2002; 113: 112–9.
Dupuis-GirodS., MedioniJ., HaddadE.Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients.Pediatrics2003; 111: e622–7.
64.
SchurmanS.H., CandottiF.Autoimmunity in Wiskott-Aldrich syndrome.Curr Opin Rheumatol2003; 15: 446–53.
65.
AslanY., ErduranE., GedikY.The role of high dose methylprednisolone and splenectomy in the accelerated phase of Chediak-Higashi syndrome.Acta Haematol1996; 96: 105–7.
66.
AtmatzidisK., PapaziogasB., MirelisC.Splenectomy versus spleen-preserving surgery for splenic echinococcosis.Dig Surg2003; 20: 527–31.
67.
PachterH.L., HofstetterS.R., ElkowitzA.Traumatic cysts of the spleen—the role of cystectomy and splenic preservation: experience with seven consecutive patients.J Trauma1993; 35: 430–6.
68.
PillarisettyV.G., KatzS.C., BleierJ.I.Natural killer dendritic cells have both antigen presenting and lytic function and in response to CpG produce IFN-gamma via autocrine IL-12.J Immunol2005; 174: 2612–8.
69.
OoiL.L., LeongS.S.Splenic abscesses from 1987 to 1995.Am J Surg1997; 174: 87–93.
70.
NelkenN., IgnatiusJ., SkinnerM., ChristensenN.Changing clinical spectrum of splenic abscess. A multicenter study and review of the literature.Am J Surg1987; 154: 27–34.
71.
UlhaciN., MeteogluI., KacarF., OzbasS.Abscess of the spleen.Pathol Oncol Res2004; 10: 234–6.
SayeedS., KoniarisL.G., KovachS.J., HirokawaT.Torsion of a wandering spleen.Surgery2002; 132: 535–6.
74.
SharmaO.P., OswanskiM.F., SingerD.Assessment of nonoperative management of blunt spleen and liver trauma.Am Surg2005; 71: 379–86.
75.
GuthA.A., PachterH.L., JacobowitzG.R.Rupture of the pathologic spleen: is there a role for nonoperative therapy?J Trauma1996; 41: 214–8.
76.
CogbillT.H., MooreE.E., JurkovichG.J.Nonoperative management of blunt splenic trauma: a multicenter experience.J Trauma1989; 29: 1312–7.
77.
HaanJ.M., BochicchioG.V., KramerN., ScaleaT.M.Nonoperative management of blunt splenic injury: a 5-year experience.J Trauma2005; 58: 492–8.
78.
CassarK., MunroA.Iatrogenic splenic injury.J R Coll Surg Edinb2002; 47: 731–41.
79.
DaviesJ.M., BarnesR., MilliganD.Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen.Clin Med2002; 2: 440–3.
80.
Scott-ConnerC.Chassin's Operative Strategy in General Surgery, 3rd Ed.Iowa City: Spring Science & Business Media;2002.
81.
RosenM., BrodyF., WalshR.M.Outcome of laparoscopic splenectomy based on hematologic indication.Surg Endosc2002; 16: 272–9.
82.
WinslowE.R., BruntL.M.Perioperative outcomes of laparoscopic versus open splenectomy: a meta-analysis with an emphasis on complications.Surgery2003; 134: 647–53.
83.
DoniniA., BaccaraniU., TerrosuG.Laparoscopic vs open splenectomy in the management of hematologic diseases.Surg Endosc1999; 13: 1220–5.
84.
HenifordB.T., ParkA., WalshR.M.Laparoscopic splenectomy in patients with normal-sized spleens versus splenomegaly: does size matter?Am Surg2001; 67: 854–7.
SmithL., LunaG., MergA.R.Laparoscopic splenectomy for treatment of splenomegaly.Am J Surg2004; 187: 618–20.
87.
RudowskiW.J.Accessory spleens: clinical significance with particular reference to the recurrence of idiopathic thrombocytopenic purpura.World J Surg1985; 9: 422–30.
88.
Bader-MeunierB., GauthierF., ArchambaudF.Long-term evaluation of the beneficial effect of subtotal splenectomy for management of hereditary spherocytosis.Blood2001; 97: 399–403.
89.
OzdoganM., BaykalA., KeskekM.Hydatid cyst of the spleen: treatment options.Int Surg2001; 86: 122–6.
90.
PachterH.L., HofstetterS.R., SpencerF.C.Evolving concepts in splenic surgery: splenorrhaphy versus splenectomy and post-splenectomy drainage: experience in 105 patients.Ann Surg1981; 194: 262–9.
91.
SchillingR.F.Spherocytosis, splenectomy, strokes, and heat attacks.Lancet1997; 350: 1677–8.
92.
HoeperM.M., NiedermeyerJ., HoffmeyerF.Pulmonary hypertension after splenectomy?Ann Intern Med1999; 130: 506–9.
van't RietM., BurgerJ.W., van MuiswinkelJ.M.Diagnosis and treatment of portal vein thrombosis following splenectomy.Br J Surg2000; 87: 1229–33.
95.
IkedaM., SekimotoM., TakiguchiS.High incidence of thrombosis of the portal venous system after laparoscopic splenectomy: a prospective study with contrast-enhanced CT scan.Ann Surg2005; 241: 208–16.
96.
RandiM.L., FabrisF., DonaS., GirolamiA.Evaluation of platelet function in postsplenectomy thrombocytosis.Folia Haematol Int Mag Klin Morphol Blutforsch1987; 114: 252–6.
97.
PimplW., DapuntO., KaindlH., ThalhamerJ.Incidence of septic and thromboembolic-related deaths after splenectomy in adults.Br J Surg1989; 76: 517–21.
98.
LynchA.M., KapilaR.Overwhelming postsplenectomy infection.Infect Dis Clin North Am1996; 10: 693–707.
99.
WaghornD.J.Overwhelming infection in asplenic patients: current best practice preventive measures are not being followed.J Clin Pathol2001; 54: 214–8.
100.
EjstrudP., KristensenB., HansenJ.B.Risk and patterns of bacteraemia after splenectomy: a population-based study.Scand J Infect Dis2000; 32: 521–5.
